During the past decades, anticancer immunotherapy has evolved from a promising
therapeutic option to a robust clinical reality. Many immunotherapeutic regimens are now …

Silks are biodegradable, biocompatible, self-assembling proteins that can also be tailored
via genetic engineering to contain specific chemical features, offering utility for drug and …

Most current cancer therapies focus on killing malignant cells, but these cells are often
genetically unstable and can become resistant to chemotherapy. Tumor-associated …

The surface of a cell represents a collection of macromolecules, which provides the cell with
a unique cellular landscape specific to the type and state of the cell. Ligands that …

Oncolytic virotherapy is a promising form of gene therapy for cancer, employing nature's own
agents to find and destroy malignant cells. The purpose of this review is to provide an …

Recognition of molecular diversity of cell surface proteomes in disease is essential for the
development of targeted therapies. Progress in targeted therapeutics requires establishing …

Oncolytic virotherapy relies on the administration of non-pathogenic viral strains that
selectively infect and kill malignant cells while favoring the elicitation of a therapeutically …

Cancer has become the number one cause of death amongst Americans, killing
approximately 1,600 people per day. Novel methods for early detection and the …

Oncolytic viruses are natural or genetically modified viral species that selectively infect and
kill neoplastic cells. Such an innate or exogenously conferred specificity has generated …

The application of liposomes in targeted therapy of lymphatic metastatic tumors has been
hampered by the low uptake rate of liposome by metastatic lymph nodes. In this report, LyP …